Skip to content
ZINOS
A Dutch academic hospital of brick and glass at first light, beside still water; no people.

Run your trials inside your Dutch hospital.

How ZINOS fits CCMO and MREC review, the NEN 7510 security standard, and Dutch rules on research data.

Trial approval in the Netherlands.

The CCMO validates each application and assigns one committee, which assesses both parts of the dossier.

  1. Protocol and dossier
  2. Submission through CTIS
  3. CCMO validation
  4. One committee, both parts
  5. Trial conduct

Dutch rules, and how ZINOS fits.

  • NEN 7510, 7512, and 7513: access logged, records secured
  • Electronic consent permitted since July 2022: eICF with signatures
  • Research exemption under the UAVG: pseudonymisation configurable

Where the record sits in the Netherlands.

With on-premise deployment, the CCMO and the committee receive what the rules require, and the trial record stays inside your hospital.

  • Hospital information system
  • Laboratory system
  • Imaging and pathology
  • Identity and access
  • Site operating system
  • Data hub
  • Local AI node
  • Audit trail
Scoped access
  • MREC
  • CCMO
  • Sponsor
  • Monitor

Dutch requirements, mapped to ZINOS.

RequirementRuleZINOS capability
Information security in healthcareNEN 7510, 7512, 7513Audit trail and access logging
Electronic consentCCMO and NVMETC guidance, 2022Tablet eICF with audit trail
Research use of health dataUAVG, Art. 24Configurable pseudonymisation, logged access
25-year trial file retentionClinical Trials Regulation, Art. 58Configurable retention and archival
Each row states a design fact about ZINOS, not a compliance claim.
A Dutch academic hospital of brick and glass at first light, beside still water; no people.

See ZINOS against Dutch rules.

Book a call on running trials in the Netherlands, and bring your DPO.

Book a demo